Hands on Alemtuzumab-experience from clinical practice: whom and how to treat

Overview of attention for article published in Multiple Sclerosis and Demyelinating Disorders, August 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

news: 1 news outlet

twitter: 1 X user

Citations

dimensions_citation: 28 Dimensions

Readers on

mendeley: 34 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 1 news story.

Multiple Sclerosis: Who, and How, to Treat with Alemtuzumab

HCP Live, 04 Aug 2016

Researchers in Germany recently reviewed the use of alemtuzumab, a monoclonal antibody used to treat relapsing remitting…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.